
    
      This clinical trial was conducted to evaluate the safety and effectiveness of the combined
      administration of Pitavastatin and Valsartan to ethnic Koreans with dyslipidemia concurrent
      with hypertension, as well as to research the influence on the pharmacodynamic interaction
      between the two drugs.
    
  